"NEBIVALVE H: Optimal Hypertension Therapy with Nebivolol and HCTZ"

May 22, 2024

NEBIVALVE H 

Nebivolol (5mg) + HCTZ (12.5mg)

Introduction

NEBIVALVE H  is a combination Nebivolol (5mg) and Hydrochlorothiazide (HCTZ) (12.5mg) combine to create a powerful medication known as NEBIVALVE H, designed to manage hypertension effectively. This combination harnesses the strengths of a beta-blocker and a diuretic, offering a dual approach to lowering blood pressure and enhancing cardiovascular health.

Mechanism of Action

Nebivolol is a beta-blocker that works by blocking beta-adrenergic receptors in the heart, leading to a decrease in heart rate and the force of contraction. This reduces the heart's workload and helps to lower blood pressure. Additionally, Nebivolol has vasodilating properties, which further aid in reducing blood pressure by relaxing blood vessels.

Hydrochlorothiazide (HCTZ) is a thiazide diuretic that helps prevent the body from absorbing too much salt, which can cause fluid retention. By increasing the amount of urine produced, HCTZ helps to reduce the volume of fluid in the blood vessels, thereby lowering blood pressure.

Benefits of Combination Therapy

The combination of Nebivolol and HCTZ in NEBIVALVE H provides a comprehensive approach to managing hypertension. This dual-action formula targets different mechanisms within the body to effectively reduce blood pressure. The beta-blocker component slows the heart rate and relaxes blood vessels, while the diuretic component helps eliminate excess fluid and salt.

Usage and Dosage

NEBIVALVE H is typically prescribed to patients who need a combination of beta-blocker and diuretic therapy to manage their blood pressure. The usual dosage is one tablet per day, taken with or without food. It is important to follow the healthcare provider's instructions and not to adjust the dose without consultation.

Potential Side Effects

Common side effects of Nebivolol may include fatigue, dizziness, and a slow heart rate. Hydrochlorothiazide can cause increased urination, electrolyte imbalance, and dehydration. Patients should report any severe or persistent side effects to their healthcare provider immediately.

Conclusion

Nebivolol (5mg) + HCTZ (12.5mg) (NEBIVALVE H) offers a robust solution for managing hypertension. Its dual-action formula provides comprehensive blood pressure control, improving cardiovascular health and reducing the risk of complications. Consult your healthcare provider to determine if this combination therapy is right for you.Steris Healthcare Pvt Ltd, founded by a group of expert professionals in the pharmaceutical industry in February 2018, operates as Sterispharma. This company, which is based in Navi Mumbai, holds certifications from WHO, GMP, and ISO. Its commitment is to provide high-quality drugs at affordable prices to its customers throughout India, following the rigorous guidelines set by the WHO. Steris offers the convenience of an online pharmacy where customers can easily buy medicines and enjoy the benefit of home delivery. At Steris, the mission is to supply a wide array of healthcare products designed to meet the varied needs of the medical community. Whether it is advanced treatments, medications for rare conditions, or basic health necessities, Sterispharma strives to serve the healthcare industry’s broad demands. The extensive product lineup from Steris includes treatments for various health areas such as Cardiology, Asthma, Respiratory issues, Nasal conditions, Diabetes, Endocrinology, Gastroenterology, Orthopedics, Anti-infectives/antibiotics, General Medicine, Urology, Neurology, Nephrology, Oncology, Gynecology, Pediatrics, Dental care, and Dermatology.

  For further information: 

 

 EMAIL:  info@sterispharma.com  / contact@sterispharma.com   

 CALL/WHATSAPP: 7877551268, 7849827488

 

   BUY NOW

 



 

 

SHARE WITH